Literature DB >> 15537360

N1-substituent effects in the selective delivery of polyamine conjugates into cells containing active polyamine transporters.

Richard Andrew Gardner1, Jean-Guy Delcros, Fanta Konate, Fred Breitbeil, Bénédicte Martin, Michael Sigman, Min Huang, Otto Phanstiel.   

Abstract

Several N(1)-arylalkylpolyamines containing various aromatic ring systems were synthesized as their respective HCl salts. The N(1)-substituents evaluated ranged in size from N(1)-benzyl, N(1)-naphthalen-1-ylmethyl, N(1)-2-(naphthalen-1-yl)ethyl, N(1)-3-(naphthalen-1-yl)propyl, N(1)-anthracen-9-ylmethyl, N(1)-2-(anthracen-9-yl)ethyl, N(1)-3-(anthracen-9-yl)propyl, and pyren-1-ylmethyl. The polyamine architecture was also altered and ranged from diamine to triamine and tetraamine systems. Biological activities in L1210 (murine leukemia), Chinese hamster ovary (CHO), and CHO's polyamine transport-deficient mutant (CHO-MG) cell lines were investigated via IC(50) cytotoxicity determinations. K(i) values for spermidine uptake were also determined in L1210 cells. The size of the N(1)-arylalkyl substituent as well as the polyamine sequence used had direct bearing on the observed cytotoxicity profiles. N(1)-Tethers longer than ethylene showed dramatic loss of selectivity for the polyamine transporter (PAT) as shown in a CHO/CHO-MG cytotoxicity screen. In summary, there are clear limits to the size of N(1)-substituents, which can be accommodated by the polyamine transporter. A direct correlation was observed between polyamine-conjugate uptake and cytotoxicity. In this regard, a cytotoxicity model was proposed, which describes a hydrophobic pocket of set dimensions adjacent to the putative PAT polyamine-binding site.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15537360     DOI: 10.1021/jm0497040

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  10 in total

Review 1.  Recent advances in the molecular biology of metazoan polyamine transport.

Authors:  R Poulin; R A Casero; D Soulet
Journal:  Amino Acids       Date:  2011-08-04       Impact factor: 3.520

Review 2.  Current status of the polyamine research field.

Authors:  Anthony E Pegg; Robert A Casero
Journal:  Methods Mol Biol       Date:  2011

3.  Thermally-Induced Substrate Release Via Intramolecular Cyclizations of Amino Esters and Amino Carbonates.

Authors:  Ralph J Knipp; Rosendo Estrada; Palaniappan Sethu; Michael H Nantz
Journal:  Tetrahedron       Date:  2014-05-01       Impact factor: 2.457

4.  Anthracene-polyamine conjugates inhibit in vitro proliferation of intraerythrocytic Plasmodium falciparum parasites.

Authors:  Jandeli Niemand; Pieter Burger; Bianca K Verlinden; Janette Reader; Annie M Joubert; Annette Kaiser; Abraham I Louw; Kiaran Kirk; Otto Phanstiel; Lyn-Marie Birkholtz
Journal:  Antimicrob Agents Chemother       Date:  2013-04-01       Impact factor: 5.191

5.  Development of Polyamine Lassos as Polyamine Transport Inhibitors.

Authors:  Aiste Dobrovolskaite; Richard Andrew Gardner; Jean-Guy Delcros; Otto Phanstiel
Journal:  ACS Med Chem Lett       Date:  2022-01-20       Impact factor: 4.345

Review 6.  Cancer pharmacoprevention: Targeting polyamine metabolism to manage risk factors for colon cancer.

Authors:  Eugene W Gerner; Elizabeth Bruckheimer; Alfred Cohen
Journal:  J Biol Chem       Date:  2018-10-24       Impact factor: 5.157

7.  Conjugation with polyamines enhances the antibacterial and anticancer activity of chloramphenicol.

Authors:  Ourania N Kostopoulou; Ekaterini C Kouvela; George E Magoulas; Thomas Garnelis; Ioannis Panagoulias; Maria Rodi; Georgios Papadopoulos; Athanasia Mouzaki; George P Dinos; Dionissios Papaioannou; Dimitrios L Kalpaxis
Journal:  Nucleic Acids Res       Date:  2014-06-17       Impact factor: 16.971

8.  Permeability of surface-modified polyamidoamine (PAMAM) dendrimers across Caco-2 cell monolayers.

Authors:  Dipak S Pisal; Venkata K Yellepeddi; Ajay Kumar; Radhey S Kaushik; Michael B Hildreth; Xiangming Guan; Srinath Palakurthi
Journal:  Int J Pharm       Date:  2007-08-26       Impact factor: 5.875

9.  ATP13A3 and caveolin-1 as potential biomarkers for difluoromethylornithine-based therapies in pancreatic cancers.

Authors:  Meenu Madan; Arjun Patel; Kristen Skruber; Dirk Geerts; Deborah A Altomare; Otto Phanstiel Iv
Journal:  Am J Cancer Res       Date:  2016-06-01       Impact factor: 6.166

10.  A putrescine-anthracene conjugate: a paradigm for selective drug delivery.

Authors:  Andrew J Palmer; Radiah A Ghani; Navneet Kaur; Otto Phanstiel; Heather M Wallace
Journal:  Biochem J       Date:  2009-12-10       Impact factor: 3.857

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.